Accredited CME-CE Activity Updates Gastroenterologists on Eosinophilic Esophagitis (EoE) Guidance
Eosinophilic esophagitis (EoE) has become a major cause of upper gastrointestinal morbidity with significant impacts on patient quality of life and an increasing incidence, currently about 1-2 cases per 2,000 people. Consensus guideline recommendations with specific diagnostic criteria are available, but practice pattern studies of US-practicing gastroenterologists have identified a lack of familiarity with EoE management guidelines and gaps in diagnostic, treatment, and monitoring aspects of patient care, as well as a lack of shared decision-making between gastroenterologists and their patients. To fill these gaps, Rockpointe and the Potomac Center for Medical Education offer a series of free accredited Continuing Medical Education (CME), Maintenance of Certification (MOC) and MIPS program in a pair of live webinars and as an on-demand webcourse until April 13, 2023.
No medications are currently FDA-approved for treating EoE, but guideline recommendations include the use of proton pump inhibitors and glucocorticosteroids. In the meantime, multiple targeted therapies (i.e., anti-interleukins, S1P modulators) are in late-stage clinical development and are likely to impact the EoE therapeutic landscape in the near future. Don’t Get Stuck In The Middle: Evidence-based Management of Eosinophilic Esophagitis is an hour-long activity geared toward gastroenterologists and other clinicians involved in the management of patients with EoE. Expert-led discussions will focus on current guideline recommendations for diagnosis, treatment, and monitoring of patients with EoE, clinical evidence of emerging EoE therapies, and strategies for implementing shared decision-making in EoE management.
At the program’s conclusion, participants should be able to:
- Use recommended criteria when making the diagnosis of eosinophilic esophagitis.
- Treat and monitor patients with EoE based on current guidelines and evidence.
- Implement shared decision-making to reach management decisions that meet the clinical and personal needs of patients with EoE.
- Assess the safety and efficacy of emerging therapies for EoE.
Live webinar dates and times:
Thursday April 28, 2022
6:00 – 7:00 PM CT (7:00 – 8:00 PM ET/4:00 – 5:00 PM PT)
Tuesday, May 17, 2022
7:00 – 8:00 PM ET (6:00 – 7:00 PM CT/4:00 – 5:00 PM PT)
This program is CME-certified and MOC/MIPS-eligible and qualifies the participant for 1 hour of credit. There is no fee for this activity, which is supported by an educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme and is jointly provided by the Potomac Center for Medical Education and Rockpointe in collaboration with Apfed, the American Partnership for Eosinophilic Disorders. Full accreditation information will be provided to participants prior to starting the course.
Through effective accredited continuing medical education, Rockpointe, a leader in educational programming with more than 26 years of experience, strives to improve and advance the quality of patient care. Its educational programs have been at the forefront of new issues in healthcare, including implementing MIPS, combatting the nation’s opioid and COVID-19 crises, recognizing issues with vaping, and utilizing technical advances in care. Sign up for Rockpointe’s CME course catalog and view a list of current educational opportunities, including on-demand webcourse offerings and live webinars, at www.rockpointe.com.
As part of its commitment to quality, Rockpointe works to inform the continuing-education community of significant quality-improvement issues through news and analysis on Policy & Medicine, which offers a daily look at legal, regulatory, and compliance issues affecting the pharmaceutical and device industry. Rockpointe also publishes Policy & Medicine Compliance Update, a monthly publication that provides a concise update on compliance issues facing the life science industry and goes in-depth into important cases, laws, and regulations in straightforward articles. At Rockpointe, education equals quality.
To register for one of the live webinars, click here. To view the enduring webcourse, click here.